Cargando…

Risk factors for portal vein thrombosis or venous thromboembolism in a large cohort of hospitalized cirrhotic patients

BACKGROUND: Portal vein thrombosis (PVT) and venous thromboembolism (VTE) are fearsome complications of liver cirrhosis. OBJECTIVES: To assess the prevalence and the main risk factors for venous thrombotic complications in hospitalized cirrhotic patients. PATIENTS/METHODS: We retrospectively reviewe...

Descripción completa

Detalles Bibliográficos
Autores principales: Faccia, Mariella, Santopaolo, Francesco, Gasbarrini, Antonio, Pompili, Maurizio, Zocco, Maria Assunta, Ponziani, Francesca Romana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9352602/
https://www.ncbi.nlm.nih.gov/pubmed/35076898
http://dx.doi.org/10.1007/s11739-022-02928-8
_version_ 1784762683780759552
author Faccia, Mariella
Santopaolo, Francesco
Gasbarrini, Antonio
Pompili, Maurizio
Zocco, Maria Assunta
Ponziani, Francesca Romana
author_facet Faccia, Mariella
Santopaolo, Francesco
Gasbarrini, Antonio
Pompili, Maurizio
Zocco, Maria Assunta
Ponziani, Francesca Romana
author_sort Faccia, Mariella
collection PubMed
description BACKGROUND: Portal vein thrombosis (PVT) and venous thromboembolism (VTE) are fearsome complications of liver cirrhosis. OBJECTIVES: To assess the prevalence and the main risk factors for venous thrombotic complications in hospitalized cirrhotic patients. PATIENTS/METHODS: We retrospectively reviewed electronic administrative discharge data of 19461 cirrhotic patients hospitalized over a 35-year period; univariate and multivariate logistic regression was used to asses risk factors for PVT or VTE and their impact on hospital stay and mortality. RESULTS: 382 out of 7445 patients (5.1%) were diagnosed with PVT and 95 (1.3%) with VTE. Liver cirrhosis complications were observed in 45% of patients. Hepatic encephalopathy (HE) (OR 13.88 [10.76–17.98] p < 0.0001), endoscopic signs of portal hypertension (OR 1.33 [1.02–1.75] p = 0.02), hepatocellular carcinoma (HCC) (OR 4.59 [3.6–5.84] p < 0.0001), diabetes (OR 1.68 [1.27–2.22] p = 0.0001), abdominal surgery/invasive procedures (OR 2.03 [1.56–2.64] p < 0.0001) emerged as independent predictors of PVT. Higher risk of VTE was observed in patients with HE (OR 3.21 [1.78–5.79] p < 0.0001), HCC (OR 1.98 [1.23–3.19] p = 0.002) or other tumors (OR 2.48 [1.42–4.32] p = 0.001), acute illnesses (infections OR 3.01 [1.84–5.05] p = 0.0001; cardiac/respiratory insufficiency OR 2.4 [1.27–4.53] p = 0.003; acute myocardial infarction/stroke OR 7.86 [1.76–35.12] p = 0.003). VTE was the only independent predictor of in-hospital mortality (OR 4.45 [1.05–18.81] p = 0.042). CONCLUSIONS: Liver disease complications related to portal hypertension, HCC or other tumors, diabetes, acute illnesses (i.e. infections, cardiac/pulmonary insufficiency, acute myocardial infarction/stroke) and abdominal interventions are associated with increased risk of PVT or VTE in hospitalized cirrhotic patients, and should be considered to define personalized preemptive approaches. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11739-022-02928-8.
format Online
Article
Text
id pubmed-9352602
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-93526022022-08-06 Risk factors for portal vein thrombosis or venous thromboembolism in a large cohort of hospitalized cirrhotic patients Faccia, Mariella Santopaolo, Francesco Gasbarrini, Antonio Pompili, Maurizio Zocco, Maria Assunta Ponziani, Francesca Romana Intern Emerg Med Im - Original BACKGROUND: Portal vein thrombosis (PVT) and venous thromboembolism (VTE) are fearsome complications of liver cirrhosis. OBJECTIVES: To assess the prevalence and the main risk factors for venous thrombotic complications in hospitalized cirrhotic patients. PATIENTS/METHODS: We retrospectively reviewed electronic administrative discharge data of 19461 cirrhotic patients hospitalized over a 35-year period; univariate and multivariate logistic regression was used to asses risk factors for PVT or VTE and their impact on hospital stay and mortality. RESULTS: 382 out of 7445 patients (5.1%) were diagnosed with PVT and 95 (1.3%) with VTE. Liver cirrhosis complications were observed in 45% of patients. Hepatic encephalopathy (HE) (OR 13.88 [10.76–17.98] p < 0.0001), endoscopic signs of portal hypertension (OR 1.33 [1.02–1.75] p = 0.02), hepatocellular carcinoma (HCC) (OR 4.59 [3.6–5.84] p < 0.0001), diabetes (OR 1.68 [1.27–2.22] p = 0.0001), abdominal surgery/invasive procedures (OR 2.03 [1.56–2.64] p < 0.0001) emerged as independent predictors of PVT. Higher risk of VTE was observed in patients with HE (OR 3.21 [1.78–5.79] p < 0.0001), HCC (OR 1.98 [1.23–3.19] p = 0.002) or other tumors (OR 2.48 [1.42–4.32] p = 0.001), acute illnesses (infections OR 3.01 [1.84–5.05] p = 0.0001; cardiac/respiratory insufficiency OR 2.4 [1.27–4.53] p = 0.003; acute myocardial infarction/stroke OR 7.86 [1.76–35.12] p = 0.003). VTE was the only independent predictor of in-hospital mortality (OR 4.45 [1.05–18.81] p = 0.042). CONCLUSIONS: Liver disease complications related to portal hypertension, HCC or other tumors, diabetes, acute illnesses (i.e. infections, cardiac/pulmonary insufficiency, acute myocardial infarction/stroke) and abdominal interventions are associated with increased risk of PVT or VTE in hospitalized cirrhotic patients, and should be considered to define personalized preemptive approaches. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11739-022-02928-8. Springer International Publishing 2022-01-25 2022 /pmc/articles/PMC9352602/ /pubmed/35076898 http://dx.doi.org/10.1007/s11739-022-02928-8 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Im - Original
Faccia, Mariella
Santopaolo, Francesco
Gasbarrini, Antonio
Pompili, Maurizio
Zocco, Maria Assunta
Ponziani, Francesca Romana
Risk factors for portal vein thrombosis or venous thromboembolism in a large cohort of hospitalized cirrhotic patients
title Risk factors for portal vein thrombosis or venous thromboembolism in a large cohort of hospitalized cirrhotic patients
title_full Risk factors for portal vein thrombosis or venous thromboembolism in a large cohort of hospitalized cirrhotic patients
title_fullStr Risk factors for portal vein thrombosis or venous thromboembolism in a large cohort of hospitalized cirrhotic patients
title_full_unstemmed Risk factors for portal vein thrombosis or venous thromboembolism in a large cohort of hospitalized cirrhotic patients
title_short Risk factors for portal vein thrombosis or venous thromboembolism in a large cohort of hospitalized cirrhotic patients
title_sort risk factors for portal vein thrombosis or venous thromboembolism in a large cohort of hospitalized cirrhotic patients
topic Im - Original
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9352602/
https://www.ncbi.nlm.nih.gov/pubmed/35076898
http://dx.doi.org/10.1007/s11739-022-02928-8
work_keys_str_mv AT facciamariella riskfactorsforportalveinthrombosisorvenousthromboembolisminalargecohortofhospitalizedcirrhoticpatients
AT santopaolofrancesco riskfactorsforportalveinthrombosisorvenousthromboembolisminalargecohortofhospitalizedcirrhoticpatients
AT gasbarriniantonio riskfactorsforportalveinthrombosisorvenousthromboembolisminalargecohortofhospitalizedcirrhoticpatients
AT pompilimaurizio riskfactorsforportalveinthrombosisorvenousthromboembolisminalargecohortofhospitalizedcirrhoticpatients
AT zoccomariaassunta riskfactorsforportalveinthrombosisorvenousthromboembolisminalargecohortofhospitalizedcirrhoticpatients
AT ponzianifrancescaromana riskfactorsforportalveinthrombosisorvenousthromboembolisminalargecohortofhospitalizedcirrhoticpatients